scholarly journals Estimating The Budget Impact Of Adding Omalizumab To Standard Therapy In Patients With Uncontrolled Severe Allergic Asthma From Private Health Care System Perspective In Brazil

2013 ◽  
Vol 16 (3) ◽  
pp. A232-A233 ◽  
Author(s):  
C. Suzuki ◽  
N.B. Santoni ◽  
N.L. Silva
Sign in / Sign up

Export Citation Format

Share Document